Testing effectiveness (Phase 2)WithdrawnNCT02190799
What this trial is testing
Anti-MERS-CoV Convalescent Plasma Therapy
Who this might be right for
Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
King Abdullah International Medical Research Center